nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—DBH—female reproductive system—cervical cancer	0.0231	0.0331	CbGeAlD
Dopamine—SLC22A2—renal system—cervical cancer	0.019	0.0272	CbGeAlD
Dopamine—DRD5—female reproductive system—cervical cancer	0.0177	0.0255	CbGeAlD
Dopamine—COMT—uterine cervix—cervical cancer	0.0163	0.0234	CbGeAlD
Dopamine—DRD5—female gonad—cervical cancer	0.0161	0.0232	CbGeAlD
Dopamine—COMT—decidua—cervical cancer	0.0155	0.0223	CbGeAlD
Dopamine—COMT—renal system—cervical cancer	0.0152	0.0219	CbGeAlD
Dopamine—COMT—endometrium—cervical cancer	0.0147	0.0212	CbGeAlD
Dopamine—COMT—mammalian vulva—cervical cancer	0.0142	0.0205	CbGeAlD
Dopamine—SLC22A3—uterine cervix—cervical cancer	0.0137	0.0197	CbGeAlD
Dopamine—COMT—uterus—cervical cancer	0.0136	0.0195	CbGeAlD
Dopamine—DBH—lymph node—cervical cancer	0.0135	0.0194	CbGeAlD
Dopamine—SLC22A1—renal system—cervical cancer	0.0134	0.0192	CbGeAlD
Dopamine—SLC22A3—renal system—cervical cancer	0.0128	0.0184	CbGeAlD
Dopamine—MAOB—uterine cervix—cervical cancer	0.0127	0.0182	CbGeAlD
Dopamine—SLC22A3—endometrium—cervical cancer	0.0124	0.0178	CbGeAlD
Dopamine—COMT—female reproductive system—cervical cancer	0.0122	0.0175	CbGeAlD
Dopamine—MAOB—decidua—cervical cancer	0.0121	0.0173	CbGeAlD
Dopamine—SLC22A3—mammalian vulva—cervical cancer	0.012	0.0172	CbGeAlD
Dopamine—MAOB—renal system—cervical cancer	0.0118	0.017	CbGeAlD
Dopamine—MAOB—endometrium—cervical cancer	0.0115	0.0165	CbGeAlD
Dopamine—HTR7—epithelium—cervical cancer	0.0114	0.0164	CbGeAlD
Dopamine—SLC6A2—decidua—cervical cancer	0.0112	0.0161	CbGeAlD
Dopamine—COMT—female gonad—cervical cancer	0.0111	0.0159	CbGeAlD
Dopamine—MAOB—mammalian vulva—cervical cancer	0.0111	0.0159	CbGeAlD
Dopamine—HTR1A—renal system—cervical cancer	0.0111	0.0159	CbGeAlD
Dopamine—COMT—vagina—cervical cancer	0.011	0.0158	CbGeAlD
Dopamine—MAOA—uterine cervix—cervical cancer	0.0108	0.0155	CbGeAlD
Dopamine—HTR7—renal system—cervical cancer	0.0106	0.0152	CbGeAlD
Dopamine—MAOB—uterus—cervical cancer	0.0106	0.0152	CbGeAlD
Dopamine—ADRB1—female reproductive system—cervical cancer	0.0103	0.0148	CbGeAlD
Dopamine—MAOA—decidua—cervical cancer	0.0103	0.0148	CbGeAlD
Dopamine—SLC22A3—female reproductive system—cervical cancer	0.0103	0.0147	CbGeAlD
Dopamine—MAOA—renal system—cervical cancer	0.0101	0.0145	CbGeAlD
Dopamine—SLC6A4—female reproductive system—cervical cancer	0.00998	0.0143	CbGeAlD
Dopamine—SLC22A5—uterine cervix—cervical cancer	0.00995	0.0143	CbGeAlD
Dopamine—MAOA—endometrium—cervical cancer	0.00977	0.014	CbGeAlD
Dopamine—SLC22A1—vagina—cervical cancer	0.0097	0.0139	CbGeAlD
Dopamine—MAOB—female reproductive system—cervical cancer	0.00949	0.0136	CbGeAlD
Dopamine—MAOA—mammalian vulva—cervical cancer	0.00945	0.0136	CbGeAlD
Dopamine—SLC22A3—female gonad—cervical cancer	0.00933	0.0134	CbGeAlD
Dopamine—SLC22A5—renal system—cervical cancer	0.00931	0.0134	CbGeAlD
Dopamine—SLC22A3—vagina—cervical cancer	0.00927	0.0133	CbGeAlD
Dopamine—MAOA—uterus—cervical cancer	0.009	0.0129	CbGeAlD
Dopamine—SLC22A5—endometrium—cervical cancer	0.009	0.0129	CbGeAlD
Dopamine—SLC6A2—female reproductive system—cervical cancer	0.00878	0.0126	CbGeAlD
Dopamine—MAOB—female gonad—cervical cancer	0.00863	0.0124	CbGeAlD
Dopamine—MAOB—vagina—cervical cancer	0.00858	0.0123	CbGeAlD
Dopamine—HTR7—female reproductive system—cervical cancer	0.00847	0.0122	CbGeAlD
Dopamine—CYP1A2—renal system—cervical cancer	0.00843	0.0121	CbGeAlD
Dopamine—MAOA—female reproductive system—cervical cancer	0.00809	0.0116	CbGeAlD
Dopamine—CYP2C19—vagina—cervical cancer	0.00748	0.0107	CbGeAlD
Dopamine—SLC22A5—female reproductive system—cervical cancer	0.00745	0.0107	CbGeAlD
Dopamine—MAOA—female gonad—cervical cancer	0.00736	0.0106	CbGeAlD
Dopamine—MAOA—vagina—cervical cancer	0.00732	0.0105	CbGeAlD
Dopamine—COMT—lymph node—cervical cancer	0.00713	0.0102	CbGeAlD
Dopamine—SLC22A5—female gonad—cervical cancer	0.00678	0.00975	CbGeAlD
Dopamine—SLC22A5—vagina—cervical cancer	0.00674	0.00969	CbGeAlD
Dopamine—CYP2C9—female reproductive system—cervical cancer	0.00641	0.00921	CbGeAlD
Dopamine—CYP2D6—renal system—cervical cancer	0.00601	0.00863	CbGeAlD
Dopamine—SLC22A3—lymph node—cervical cancer	0.006	0.00862	CbGeAlD
Dopamine—MAOB—lymph node—cervical cancer	0.00555	0.00797	CbGeAlD
Dopamine—SLC6A2—lymph node—cervical cancer	0.00514	0.00738	CbGeAlD
Dopamine—CYP2D6—female reproductive system—cervical cancer	0.00481	0.00691	CbGeAlD
Dopamine—MAOA—lymph node—cervical cancer	0.00473	0.0068	CbGeAlD
Dopamine—CYP2D6—female gonad—cervical cancer	0.00438	0.00629	CbGeAlD
Dopamine—SLC22A5—lymph node—cervical cancer	0.00436	0.00627	CbGeAlD
Dopamine—SLC6A3—Parkinsons Disease Pathway—CASP3—cervical cancer	0.00153	0.00504	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00153	0.00503	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—WNT2—cervical cancer	0.00152	0.00501	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—TAAR6—cervical cancer	0.0015	0.00495	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00146	0.00482	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—TAAR6—cervical cancer	0.00144	0.00474	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—HES1—cervical cancer	0.00143	0.00472	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—UBE3A—cervical cancer	0.00141	0.00463	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—TAAR6—cervical cancer	0.0013	0.00426	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00129	0.00423	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—TAAR6—cervical cancer	0.00128	0.00421	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00125	0.00411	CbGpPWpGaD
Dopamine—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00121	0.00396	CbGpPWpGaD
Dopamine—DBH—Metabolism—CA9—cervical cancer	0.00119	0.00392	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—WNT2—cervical cancer	0.00117	0.00386	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—TAAR6—cervical cancer	0.00117	0.00383	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—WNT5A—cervical cancer	0.00115	0.0038	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—WNT2—cervical cancer	0.00112	0.0037	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.00112	0.00367	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—TAAR6—cervical cancer	0.0011	0.00363	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—NOTCH1—cervical cancer	0.00108	0.00356	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00102	0.00337	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—WNT2—cervical cancer	0.00101	0.00333	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.001	0.0033	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—TAAR6—cervical cancer	0.001	0.00329	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—WNT2—cervical cancer	0.000999	0.00328	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—TAAR6—cervical cancer	0.000979	0.00322	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—WNT2—cervical cancer	0.00091	0.00299	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—WNT5A—cervical cancer	0.00089	0.00293	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.000871	0.00286	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00087	0.00286	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—WNT5A—cervical cancer	0.000852	0.0028	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—TAAR6—cervical cancer	0.00085	0.0028	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—TAAR6—cervical cancer	0.000814	0.00268	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—WNT2—cervical cancer	0.000782	0.00257	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—TAAR6—cervical cancer	0.000772	0.00254	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—WNT5A—cervical cancer	0.000767	0.00252	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—WNT2—cervical cancer	0.000764	0.00251	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—WNT5A—cervical cancer	0.000757	0.00249	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—AKAP13—cervical cancer	0.000756	0.00249	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—TAAR6—cervical cancer	0.000739	0.00243	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—TAAR6—cervical cancer	0.000733	0.00241	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—TAAR6—cervical cancer	0.000723	0.00238	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—CTNNB1—cervical cancer	0.00072	0.00237	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—WNT5A—cervical cancer	0.00069	0.00227	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—AKAP13—cervical cancer	0.000686	0.00226	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—TAAR6—cervical cancer	0.000665	0.00219	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.00066	0.00217	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—TAAR6—cervical cancer	0.000659	0.00217	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—TAAR6—cervical cancer	0.000657	0.00216	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00065	0.00214	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00063	0.00207	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—STAT3—cervical cancer	0.000627	0.00206	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000626	0.00206	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—WNT2—cervical cancer	0.000603	0.00198	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—TAAR6—cervical cancer	0.000598	0.00197	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—WNT5A—cervical cancer	0.000593	0.00195	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TAAR6—cervical cancer	0.000592	0.00195	CbGpPWpGaD
Dopamine—COMT—Metabolism—CA9—cervical cancer	0.000589	0.00194	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKAP13—cervical cancer	0.000583	0.00192	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.000579	0.0019	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—WNT2—cervical cancer	0.000577	0.0019	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.000572	0.00188	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—EGFR—cervical cancer	0.00057	0.00187	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CA9—cervical cancer	0.000559	0.00184	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKAP13—cervical cancer	0.000558	0.00183	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.000553	0.00182	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000533	0.00175	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKAP13—cervical cancer	0.000529	0.00174	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—WNT2—cervical cancer	0.00052	0.00171	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000513	0.00169	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—WNT2—cervical cancer	0.000513	0.00169	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKAP13—cervical cancer	0.000507	0.00167	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.000502	0.00165	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.000502	0.00165	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKAP13—cervical cancer	0.000496	0.00163	CbGpPWpGaD
Dopamine—DBH—Metabolism—MTHFR—cervical cancer	0.000484	0.00159	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CA9—cervical cancer	0.000473	0.00155	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—WNT2—cervical cancer	0.000467	0.00154	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—WNT2—cervical cancer	0.000462	0.00152	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—WNT5A—cervical cancer	0.000457	0.0015	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TAAR6—cervical cancer	0.000456	0.0015	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKAP13—cervical cancer	0.000456	0.0015	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000453	0.00149	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKAP13—cervical cancer	0.000452	0.00148	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKAP13—cervical cancer	0.00045	0.00148	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.000447	0.00147	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—WNT5A—cervical cancer	0.000437	0.00144	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TAAR6—cervical cancer	0.000437	0.00144	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000436	0.00144	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000432	0.00142	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKAP13—cervical cancer	0.00041	0.00135	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKAP13—cervical cancer	0.000406	0.00133	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000399	0.00131	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000399	0.00131	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—WNT5A—cervical cancer	0.000394	0.00129	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TAAR6—cervical cancer	0.000393	0.00129	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.000392	0.00129	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.000392	0.00129	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—WNT5A—cervical cancer	0.000388	0.00128	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TAAR6—cervical cancer	0.000388	0.00128	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.000379	0.00125	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—WNT2—cervical cancer	0.000356	0.00117	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—WNT5A—cervical cancer	0.000354	0.00116	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TAAR6—cervical cancer	0.000353	0.00116	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CA9—cervical cancer	0.000351	0.00115	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—WNT5A—cervical cancer	0.00035	0.00115	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.000344	0.00113	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—WNT2—cervical cancer	0.000341	0.00112	CbGpPWpGaD
Dopamine—SLC6A4—Circadian rythm related genes—TP53—cervical cancer	0.00034	0.00112	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.000339	0.00111	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.000338	0.00111	CbGpPWpGaD
Dopamine—HTR7—Circadian rythm related genes—TP53—cervical cancer	0.00032	0.00105	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKAP13—cervical cancer	0.000313	0.00103	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—WNT2—cervical cancer	0.000307	0.00101	CbGpPWpGaD
Dopamine—DRD4—Circadian rythm related genes—TP53—cervical cancer	0.000306	0.00101	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—WNT2—cervical cancer	0.000303	0.000996	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.000299	0.000984	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000297	0.000978	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000297	0.000976	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CA9—cervical cancer	0.000297	0.000975	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CA9—cervical cancer	0.000276	0.000909	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—WNT2—cervical cancer	0.000276	0.000907	CbGpPWpGaD
Dopamine—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.000276	0.000906	CbGpPWpGaD
Dopamine—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.000272	0.000894	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—WNT5A—cervical cancer	0.00027	0.000888	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000269	0.000886	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000266	0.000874	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000264	0.000868	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.000258	0.00085	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NOTCH2—cervical cancer	0.000246	0.000808	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKAP13—cervical cancer	0.000242	0.000797	CbGpPWpGaD
Dopamine—COMT—Metabolism—MTHFR—cervical cancer	0.000239	0.000787	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000233	0.000765	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000232	0.000762	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000232	0.000762	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000229	0.000755	CbGpPWpGaD
Dopamine—MAOB—Metabolism—MTHFR—cervical cancer	0.000227	0.000746	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—WNT5A—cervical cancer	0.000209	0.000688	CbGpPWpGaD
Dopamine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000208	0.000684	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000203	0.000669	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HES1—cervical cancer	0.000201	0.000662	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.0002	0.000658	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—MTHFR—cervical cancer	0.000192	0.000631	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.000189	0.000623	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000181	0.000596	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TERT—cervical cancer	0.000177	0.00058	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000176	0.000577	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CA9—cervical cancer	0.000166	0.000546	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000163	0.000537	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000162	0.000533	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000161	0.00053	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HES1—cervical cancer	0.000155	0.000511	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CA9—cervical cancer	0.000153	0.000502	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000152	0.0005	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CA9—cervical cancer	0.000151	0.000498	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HES1—cervical cancer	0.000149	0.000489	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.000147	0.000483	CbGpPWpGaD
Dopamine—MAOA—Metabolism—MTHFR—cervical cancer	0.000142	0.000468	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.00014	0.000462	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TERT—cervical cancer	0.000136	0.000448	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000135	0.000446	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000134	0.00044	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HES1—cervical cancer	0.000132	0.000434	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TERT—cervical cancer	0.00013	0.000428	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CA9—cervical cancer	0.000129	0.000425	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000125	0.000411	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000123	0.000405	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HES1—cervical cancer	0.00012	0.000396	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MTHFR—cervical cancer	0.00012	0.000396	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.00012	0.000393	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000117	0.000386	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000386	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000116	0.000381	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000115	0.000378	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000114	0.000375	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000112	0.000369	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MTHFR—cervical cancer	0.000112	0.000369	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000108	0.000354	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000106	0.000349	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TERT—cervical cancer	0.000105	0.000347	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000105	0.000345	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—EGFR—cervical cancer	0.000104	0.000344	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000101	0.000332	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000101	0.000332	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000101	0.000332	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000101	0.000332	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.0001	0.000329	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	9.97e-05	0.000328	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FGFR3—cervical cancer	9.68e-05	0.000318	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	9.26e-05	0.000304	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	9.08e-05	0.000299	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—cervical cancer	9e-05	0.000296	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—cervical cancer	8.88e-05	0.000292	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TERT—cervical cancer	8.85e-05	0.000291	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—STAT3—cervical cancer	8.81e-05	0.00029	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MTOR—cervical cancer	8.79e-05	0.000289	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	8.69e-05	0.000286	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MTOR—cervical cancer	8.41e-05	0.000277	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGFR3—cervical cancer	8.13e-05	0.000267	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—cervical cancer	8.09e-05	0.000266	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—cervical cancer	8.08e-05	0.000266	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—cervical cancer	8e-05	0.000263	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	7.79e-05	0.000256	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	7.74e-05	0.000255	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—cervical cancer	7.74e-05	0.000254	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	7.63e-05	0.000251	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MTOR—cervical cancer	7.57e-05	0.000249	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MTOR—cervical cancer	7.47e-05	0.000246	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	7.46e-05	0.000245	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—cervical cancer	6.96e-05	0.000229	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—cervical cancer	6.87e-05	0.000226	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MTOR—cervical cancer	6.81e-05	0.000224	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—cervical cancer	6.8e-05	0.000224	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—cervical cancer	6.79e-05	0.000223	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—cervical cancer	6.73e-05	0.000221	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—cervical cancer	6.72e-05	0.000221	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	6.71e-05	0.000221	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	6.62e-05	0.000218	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MTOR—cervical cancer	6.51e-05	0.000214	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—cervical cancer	6.5e-05	0.000214	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—cervical cancer	6.26e-05	0.000206	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—cervical cancer	6.19e-05	0.000204	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—cervical cancer	6.17e-05	0.000203	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—cervical cancer	6.14e-05	0.000202	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	6.03e-05	0.000198	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—cervical cancer	5.99e-05	0.000197	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—cervical cancer	5.91e-05	0.000194	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—cervical cancer	5.85e-05	0.000192	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—cervical cancer	5.77e-05	0.00019	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	5.77e-05	0.00019	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MTOR—cervical cancer	5.72e-05	0.000188	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—cervical cancer	5.32e-05	0.000175	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—cervical cancer	5.26e-05	0.000173	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—cervical cancer	5.26e-05	0.000173	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—cervical cancer	5.25e-05	0.000173	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—cervical cancer	5.25e-05	0.000173	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—cervical cancer	5.18e-05	0.00017	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	5.07e-05	0.000167	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—cervical cancer	5.03e-05	0.000165	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—cervical cancer	4.96e-05	0.000163	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—cervical cancer	4.78e-05	0.000157	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—cervical cancer	4.57e-05	0.00015	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—cervical cancer	4.47e-05	0.000147	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—cervical cancer	4.42e-05	0.000145	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—cervical cancer	4.41e-05	0.000145	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—cervical cancer	4.02e-05	0.000132	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—cervical cancer	4.01e-05	0.000132	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—cervical cancer	3.84e-05	0.000126	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—cervical cancer	3.37e-05	0.000111	CbGpPWpGaD
